CHINA PHARMA HOLDINGS, INC. (CPHI) Net margin 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) net profit margin by fiscal year — reported net income divided by reported revenue.
-76.9%FY2025 · since FY2016: -59.0% → -76.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -76.9% | +27.7 pp |
| FY2024 | -104.6% | -60.7 pp |
| FY2023 | -43.9% | +5.1 pp |
| FY2022 | -49.0% | -13.8 pp |
| FY2021 | -35.3% | -8.9 pp |
| FY2020 | -26.4% | +163.1 pp |
| FY2019 | -189.5% | -102.3 pp |
| FY2018 | -87.2% | +58.7 pp |
| FY2017 | -145.9% | -86.9 pp |
| FY2016 | -59.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPHI financial trends
CPHI RevenueCPHI Net incomeCPHI Gross profitCPHI Gross marginCPHI Operating incomeCPHI Operating marginCPHI Operating cash flowCPHI Free cash flowCPHI Capital expendituresCPHI Return on equityCPHI Stock buybacksCPHI Dividends paidCPHI Total assetsCPHI Total liabilitiesCPHI Shareholders’ equityCPHI overview →